Drug Testing and Analysis

Cover image for Vol. 9 Issue 6

Editor-in-Chief: Prof. Mario Thevis

Impact Factor: 3.469

ISI Journal Citation Reports © Ranking: 2016: 15/76 (Chemistry Analytical); 25/77 (BIOCHEMICAL RESEARCH METHODS); 62/256 (Pharmacology & Pharmacy)

Online ISSN: 1942-7611

Most Cited

Data derived from Thomson Reuters© Web of Science SM

Sewage-based epidemiology in monitoring the use of new psychoactive substances: Validation and application of an analytical method using LC-MS/MS

Annual banned-substance review: analytical approaches in human sports drug testing

Synthetic cannabimimetic agents metabolized by carboxylesterases

Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study

Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry

Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MSn standard screening approaches

High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes

An amphetamine isomer whose efficacy and safety in humans has never been studied, -methylphenylethylamine (BMPEA), is found in multiple dietary supplements

Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens

Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health